Latest News
PnuVax awarded $29.4 million USD grant to advance innovative vaccine into clinical trials
PnuVax Announces Deal with GE for Inactivated Yellow Fever Vaccine IP
PnuVax Announces Preclinical In-vivo Pneumococcal Conjugate Vaccine Immunogenicity Results
PnuVax Homepage